Selected research
Industry Research
Organic Pharmaceutical Excipients Industry Research Report 2026
Market perspective
The global Organic Pharmaceutical Excipients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Organic Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Organic Pharmaceutical Excipients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Organic Pharmaceutical Excipients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Organic Pharmaceutical Excipients include Wacker Chemie, Roquette, Lubrizol, Kerry, Innophos Holdings, Evonik Industries, Dowdupont, Croda and BASF, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Organic Pharmaceutical Excipients market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons ), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons ) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Organic Pharmaceutical Excipients Market by Company
Wacker Chemie
Roquette
Lubrizol
Kerry
Innophos Holdings
Evonik Industries
Dowdupont
Croda
BASF
Associated British Foods
Ashland
Archer Daniels Midland
Organic Pharmaceutical Excipients Segment by Type
Oleochemicals
Carbohydrates
Petrochemicals
Protein
Others
Organic Pharmaceutical Excipients Segment by Application
Oral Formulations
Topical Formulations
Parenteral Formulations
Others
Organic Pharmaceutical Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organic Pharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organic Pharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organic Pharmaceutical Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Organic Pharmaceutical Excipients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Organic Pharmaceutical Excipients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Organic Pharmaceutical Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oleochemicals
- Carbohydrates
- Petrochemicals
- Protein
- Others
Applications
- Oral Formulations
- Topical Formulations
- Parenteral Formulations
- Others
Companies covered
- Wacker Chemie
- Roquette
- Lubrizol
- Kerry
- Innophos Holdings
- Evonik Industries
- Dowdupont
- Croda
- BASF
- Associated British Foods
- Ashland
- Archer Daniels Midland
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Organic Pharmaceutical Excipients Market Size (2021-2032)
- 2.2.2 Global Organic Pharmaceutical Excipients Sales (2021-2032)
- 2.2.3 Global Organic Pharmaceutical Excipients Market Average Price (2021-2032)
- 2.3 Organic Pharmaceutical Excipients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oleochemicals
- 2.3.3 Carbohydrates
- 2.3.4 Petrochemicals
- 2.3.5 Protein
- 2.3.6 Others
- 2.4 Organic Pharmaceutical Excipients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oral Formulations
- 2.4.3 Topical Formulations
- 2.4.4 Parenteral Formulations
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Organic Pharmaceutical Excipients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Organic Pharmaceutical Excipients Sales (W Tons ) of Manufacturers (2021-2026)
- 3.3 Global Organic Pharmaceutical Excipients Revenue of Manufacturers (2021-2026)
- 3.4 Global Organic Pharmaceutical Excipients Average Price by Manufacturers (2021-2026)
- 3.5 Global Organic Pharmaceutical Excipients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Organic Pharmaceutical Excipients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Organic Pharmaceutical Excipients, Product Type & Application
- 3.8 Global Manufacturers of Organic Pharmaceutical Excipients, Established Date
- 3.9 Global Organic Pharmaceutical Excipients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wacker Chemie
- 4.1.1 Wacker Chemie Company Information
- 4.1.2 Wacker Chemie Business Overview
- 4.1.3 Wacker Chemie Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wacker Chemie Organic Pharmaceutical Excipients Product Portfolio
- 4.1.5 Wacker Chemie Recent Developments
- 4.2 Roquette
- 4.2.1 Roquette Company Information
- 4.2.2 Roquette Business Overview
- 4.2.3 Roquette Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roquette Organic Pharmaceutical Excipients Product Portfolio
- 4.2.5 Roquette Recent Developments
- 4.3 Lubrizol
- 4.3.1 Lubrizol Company Information
- 4.3.2 Lubrizol Business Overview
- 4.3.3 Lubrizol Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lubrizol Organic Pharmaceutical Excipients Product Portfolio
- 4.3.5 Lubrizol Recent Developments
- 4.4 Kerry
- 4.4.1 Kerry Company Information
- 4.4.2 Kerry Business Overview
- 4.4.3 Kerry Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kerry Organic Pharmaceutical Excipients Product Portfolio
- 4.4.5 Kerry Recent Developments
- 4.5 Innophos Holdings
- 4.5.1 Innophos Holdings Company Information
- 4.5.2 Innophos Holdings Business Overview
- 4.5.3 Innophos Holdings Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Innophos Holdings Organic Pharmaceutical Excipients Product Portfolio
- 4.5.5 Innophos Holdings Recent Developments
- 4.6 Evonik Industries
- 4.6.1 Evonik Industries Company Information
- 4.6.2 Evonik Industries Business Overview
- 4.6.3 Evonik Industries Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Evonik Industries Organic Pharmaceutical Excipients Product Portfolio
- 4.6.5 Evonik Industries Recent Developments
- 4.7 Dowdupont
- 4.7.1 Dowdupont Company Information
- 4.7.2 Dowdupont Business Overview
- 4.7.3 Dowdupont Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dowdupont Organic Pharmaceutical Excipients Product Portfolio
- 4.7.5 Dowdupont Recent Developments
- 4.8 Croda
- 4.8.1 Croda Company Information
- 4.8.2 Croda Business Overview
- 4.8.3 Croda Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Croda Organic Pharmaceutical Excipients Product Portfolio
- 4.8.5 Croda Recent Developments
- 4.9 BASF
- 4.9.1 BASF Company Information
- 4.9.2 BASF Business Overview
- 4.9.3 BASF Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BASF Organic Pharmaceutical Excipients Product Portfolio
- 4.9.5 BASF Recent Developments
- 4.10 Associated British Foods
- 4.10.1 Associated British Foods Company Information
- 4.10.2 Associated British Foods Business Overview
- 4.10.3 Associated British Foods Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Associated British Foods Organic Pharmaceutical Excipients Product Portfolio
- 4.10.5 Associated British Foods Recent Developments
- 4.11 Ashland
- 4.11.1 Ashland Company Information
- 4.11.2 Ashland Business Overview
- 4.11.3 Ashland Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ashland Organic Pharmaceutical Excipients Product Portfolio
- 4.11.5 Ashland Recent Developments
- 4.12 Archer Daniels Midland
- 4.12.1 Archer Daniels Midland Company Information
- 4.12.2 Archer Daniels Midland Business Overview
- 4.12.3 Archer Daniels Midland Organic Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Archer Daniels Midland Organic Pharmaceutical Excipients Product Portfolio
- 4.12.5 Archer Daniels Midland Recent Developments
5 Global Organic Pharmaceutical Excipients Market Scenario by Region
- 5.1 Global Organic Pharmaceutical Excipients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Organic Pharmaceutical Excipients Sales by Region: 2021-2032
- 5.2.1 Global Organic Pharmaceutical Excipients Sales by Region: 2021-2026
- 5.2.2 Global Organic Pharmaceutical Excipients Sales by Region: 2027-2032
- 5.3 Global Organic Pharmaceutical Excipients Revenue by Region: 2021-2032
- 5.3.1 Global Organic Pharmaceutical Excipients Revenue by Region: 2021-2026
- 5.3.2 Global Organic Pharmaceutical Excipients Revenue by Region: 2027-2032
- 5.4 North America Organic Pharmaceutical Excipients Market Facts & Figures by Country
- 5.4.1 North America Organic Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Organic Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.4.3 North America Organic Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Organic Pharmaceutical Excipients Market Facts & Figures by Country
- 5.5.1 Europe Organic Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Organic Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.5.3 Europe Organic Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Organic Pharmaceutical Excipients Market Facts & Figures by Country
- 5.6.1 Asia Pacific Organic Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Organic Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Organic Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Organic Pharmaceutical Excipients Market Facts & Figures by Country
- 5.7.1 South America Organic Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Organic Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.7.3 South America Organic Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Organic Pharmaceutical Excipients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Organic Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Organic Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Organic Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Organic Pharmaceutical Excipients Sales by Type (2021-2032)
- 6.1.1 Global Organic Pharmaceutical Excipients Sales by Type (2021-2032) & (W Tons )
- 6.1.2 Global Organic Pharmaceutical Excipients Sales Market Share by Type (2021-2032)
- 6.2 Global Organic Pharmaceutical Excipients Revenue by Type (2021-2032)
- 6.2.1 Global Organic Pharmaceutical Excipients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Organic Pharmaceutical Excipients Revenue Market Share by Type (2021-2032)
- 6.3 Global Organic Pharmaceutical Excipients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Organic Pharmaceutical Excipients Sales by Application (2021-2032)
- 7.1.1 Global Organic Pharmaceutical Excipients Sales by Application (2021-2032) & (W Tons )
- 7.1.2 Global Organic Pharmaceutical Excipients Sales Market Share by Application (2021-2032)
- 7.2 Global Organic Pharmaceutical Excipients Revenue by Application (2021-2032)
- 7.2.1 Global Organic Pharmaceutical Excipients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Organic Pharmaceutical Excipients Revenue Market Share by Application (2021-2032)
- 7.3 Global Organic Pharmaceutical Excipients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Organic Pharmaceutical Excipients Value Chain Analysis
- 8.1.1 Organic Pharmaceutical Excipients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Organic Pharmaceutical Excipients Production Mode & Process
- 8.2 Organic Pharmaceutical Excipients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Organic Pharmaceutical Excipients Distributors
- 8.2.3 Organic Pharmaceutical Excipients Customers
9 Global Organic Pharmaceutical Excipients Analyzing Market Dynamics
- 9.1 Organic Pharmaceutical Excipients Industry Trends
- 9.2 Organic Pharmaceutical Excipients Industry Drivers
- 9.3 Organic Pharmaceutical Excipients Industry Opportunities and Challenges
- 9.4 Organic Pharmaceutical Excipients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst